Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
US Department of Justice
Cantor Fitzgerald
Fish and Richardson
Julphar
Teva
Boehringer Ingelheim
UBS
Healthtrust

Generated: October 21, 2018

DrugPatentWatch Database Preview

VALEANT LUXEMBOURG Company Profile

« Back to Dashboard

What is the competitive landscape for VALEANT LUXEMBOURG, and what generic and branded alternatives to VALEANT LUXEMBOURG drugs are available?

VALEANT LUXEMBOURG has six approved drugs.



Summary for VALEANT LUXEMBOURG
US Patents:0
Tradenames:4
Ingredients:5
NDAs:6

Drugs and US Patents for VALEANT LUXEMBOURG

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Luxembourg TARGRETIN bexarotene GEL;TOPICAL 021056-001 Jun 28, 2000 RX Yes Yes ➤ Sign Up ➤ Sign Up
Valeant Luxembourg ERTACZO sertaconazole nitrate CREAM;TOPICAL 021385-001 Dec 10, 2003 RX Yes Yes ➤ Sign Up ➤ Sign Up
Valeant Luxembourg GRIFULVIN V griseofulvin, microcrystalline TABLET;ORAL 062279-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for VALEANT LUXEMBOURG

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Luxembourg TARGRETIN bexarotene CAPSULE;ORAL 021055-001 Dec 29, 1999 6,320,074 ➤ Sign Up
Valeant Luxembourg VISUDYNE verteporfin INJECTABLE;INJECTION 021119-001 Apr 12, 2000 5,095,030 ➤ Sign Up
Valeant Luxembourg VISUDYNE verteporfin INJECTABLE;INJECTION 021119-001 Apr 12, 2000 4,883,790 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for VALEANT LUXEMBOURG drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 75 mg ➤ Subscribe 2011-06-06
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Citi
McKesson
Daiichi Sankyo
Accenture
Moodys
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.